Europe Pemphigus Vulgaris Treatment Market Research Report: Forecast (2025-2030)

Europe Pemphigus Vulgaris Treatment Market - By Treatment Type (Corticosteroids, Immunosuppressants, Biologics, [Rituximab, Intravenous Immunoglobulin (IVIG)], Antibiotics, Plasmapheresis), By Distrib... ... heresis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialty Clinics, Homecare Settings) and others Read more

  • Healthcare
  • Jun 2025
  • 184
  • PDF, Excel, PPT

Market Definition

Pemphigus Vulgaris (PV) is a type of autoimmune disease that is rarely found, in which the body’s immune system attacks the skin and mouth linings and results in the formation of fluid-filled, painful blisters and sores.

Market Insights & Analysis: Europe Pemphigus Vulgaris Treatment Market (2025-30):

The Europe Pemphigus Vulgaris Treatment Market size was valued at around USD106.15 million in 2024 and is expected to reach USD169.38 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.10% during the forecast period, i.e., 2025-30. The market is substantially growing, which is stimulated by various factors, including the high prevalence of autoimmune diseases such as Pemphigus Vulgaris (PV) in European countries, the robust research and developments, significant investments by various national governments, the innovation of advanced treatments such as biologic drugs, and biomarker therapies, etc. One of the core reasons for this incidence is the higher genetic predisposition in the European population, which includes genetic factors like Human Leucocyte Antigen (HLA). These genes are proactively responsible for the PV disease in Europe.

Report Coverage Details
Historical Years 2020–23
Forecast Years 2025–30
Market Value in 2024 USD 106.15 Million
Market Value by 2030 USD 169.38 Million
CAGR (2025–30) 8.10%
Top Key Players Roche Holding AG, GlaxoSmithKline plc, Pfizer Inc., Novartis AG, Sanofi S.A., Johnson & Johnson (Janssen Pharmaceuticals), AstraZeneca plc, Amgen Inc., UCB S.A., Others
Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation
  • Recent Strategic Moves by Companies
  • Primary Stakeholders
  • Import/Export Trend Analysis
  • Competitive Landscape Assessment
  • Emerging Opportunities
  • Market Trends and Indicators

 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Additionally, the governments of France, Germany, the UK, etc. are actively supporting the clinical and pre-clinical trials for advanced therapies and treatments for PV by profoundly investing in these kinds of projects. It is providing potential growth opportunities to the European Pemphigus Vulgaris Market by attracting advancements in treatment procedures. Also, the biologics treatment is gaining popularity in the market due to its high efficiency, efficacy, safety, and quality. Moreover, hospital pharmacies are dominating the market based on the distribution channel segment due to easy retailing and a prime spot for customer preference. This market is specifically dominating in Germany due to having a robust healthcare infrastructure and strong government support.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Europe Pemphigus Vulgaris Treatment Market Supply Chain Analysis
  5. Europe Pemphigus Vulgaris Treatment Market Import-Export Analysis
  6. Europe Pemphigus Vulgaris Treatment Market Trends & Insights
  7. Europe Pemphigus Vulgaris Treatment Market Dynamics
    1. Growth Drivers
    2. Challenges
  8. Europe Pemphigus Vulgaris Treatment Market Hotspot & Opportunities
  9. Europe Pemphigus Vulgaris Treatment Market Standards & Regulations
  10. Europe Pemphigus Vulgaris Treatment Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Treatment Type
        1. Corticosteroids– Market Size & Forecast 2020-2030F, USD Million
        2. Immunosuppressants– Market Size & Forecast 2020-2030F, USD Million
        3. Biologics– Market Size & Forecast 2020-2030F, USD Million
          1. Rituximab– Market Size & Forecast 2020-2030F, USD Million
          2. Intravenous Immunoglobulin (IVIG)– Market Size & Forecast 2020-2030F, USD Million
        4. Antibiotics– Market Size & Forecast 2020-2030F, USD Million
        5. Plasmapheresis– Market Size & Forecast 2020-2030F, USD Million
      2. By Distribution Channel
        1. Hospital Pharmacies– Market Size & Forecast 2020-2030F, USD Million
        2. Retail Pharmacies– Market Size & Forecast 2020-2030F, USD Million
        3. Online Pharmacies– Market Size & Forecast 2020-2030F, USD Million
      3. By End-User
        1. Hospitals– Market Size & Forecast 2020-2030F, USD Million
        2. Specialty Clinics– Market Size & Forecast 2020-2030F, USD Million
        3. Homecare Settings– Market Size & Forecast 2020-2030F, USD Million
      4. By Country/Region
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      5.  By Company
        1. Competition Characteristics
        2. Market Share & Analysis
  11. Germany Pemphigus Vulgaris Treatment Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By KVA Ratings– Market Size & Forecast 2020-2030F, USD Million
      2. By End-Users– Market Size & Forecast 2020-2030F, USD Million
  12. United Kingdom Pemphigus Vulgaris Treatment Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By KVA Ratings– Market Size & Forecast 2020-2030F, USD Million
      2. By End-Users– Market Size & Forecast 2020-2030F, USD Million
  13. France Pemphigus Vulgaris Treatment Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By KVA Ratings– Market Size & Forecast 2020-2030F, USD Million
      2. By End-Users– Market Size & Forecast 2020-2030F, USD Million
  14. Italy Pemphigus Vulgaris Treatment Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By KVA Ratings– Market Size & Forecast 2020-2030F, USD Million
      2. By End-Users– Market Size & Forecast 2020-2030F, USD Million
  15. Spain Pemphigus Vulgaris Treatment Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By KVA Ratings– Market Size & Forecast 2020-2030F, USD Million
      2. By End-Users– Market Size & Forecast 2020-2030F, USD Million
  16. Europe Pemphigus Vulgaris Treatment Market Key Strategic Imperatives for Success & Growth
  17. Competition Outlook
    1. Company profiles
      1. Roche Holding AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. GlaxoSmithKline plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Pfizer Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Novartis AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Sanofi S.A.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Johnson & Johnson (Janssen Pharmaceuticals)
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. AstraZeneca plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Amgen Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. UCB S.A.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances/Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Others
  18. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .